Tenofovir-DF Versus Hydroxychloroquine in the Treatment of Hospitalized Patients With COVID-19 (TEDHICOV)
CompletedOBSERVATIONAL
Enrollment
100
Participants
Timeline
Start Date
March 1, 2020
Primary Completion Date
May 30, 2020
Study Completion Date
January 15, 2021
Conditions
Covid19SARS-CoV InfectionTenofovir
Trial Locations (1)
04001
Hospital Nacional CASE - EsSalud, Arequipa
All Listed Sponsors
lead
Hospital Nacional Carlos Alberto Seguin Escobedo - EsSalud
OTHER
NCT04812496 - Tenofovir-DF Versus Hydroxychloroquine in the Treatment of Hospitalized Patients With COVID-19 (TEDHICOV) | Biotech Hunter | Biotech Hunter